Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Seller: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Seller: Basi6 International, Irving, TX, U.S.A.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Seller: SMASS Sellers, IRVING, TX, U.S.A.
Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
Seller: SMASS Sellers, IRVING, TX, U.S.A.
Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. 1st edition NO-PA16APR2015-KAP.
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New.
Language: English
Published by Taylor and Francis Ltd, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New.
Language: English
Published by Taylor and Francis Ltd, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.
Condition: NEW.
Language: English
Published by Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
Paperback. Condition: New. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Language: English
Published by Taylor & Francis Ltd, London, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
Paperback. Condition: new. Paperback. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD. This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Language: English
Published by Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Seller: Rarewaves USA, OSWEGO, IL, U.S.A.
Paperback. Condition: New. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD.
Language: German
Published by Buchs (Schweiz). BuchsDruck und Verlag., 1988
Seller: Antiquariat Heinzelmännchen, Stuttgart, Germany
63, (1) Seiten. Mit zahlreichen teils ganzseitigen u. farbigen Abbildungen. Farbig ill. OKart.-Einband u. Original-Pergamin-Schutzumschlag. 26x21 cm * Home Aktuell Bilder 2016 Bilder 2017 weitere Bilder 2017 Serien/Fächer/Zwischenraum 2017 Zwischenraum 2017 Bilder 2017/2 secret signs 2018 Babylon 2018 Triptychon Va Pensiero 2018 femme fatale 2018 Bilder 2018 Bergleuchteen 2018 Bilder 2019 Weitere Bilder 2019 Spalierzeichen 2019 Grosse Formate 2019/2020 Biografie Ausstellungskalender Gruppenausstellungen Verschiedene Stimmen 1 Verschiedene Stimmen 2 Internationale Kunst heute Ein Erlebnisbericht. Walter Grässli Geboren 1943, in Werdenberg SG. Lehre als Maler, Dekorations- und Schriftenmaler. Sein Weg verläuft zuerst autodidaktisch. Die notwendigen Grundlagen das, was man in einem Vorkurs an einer Schule für Gestaltung lernt bringt er sich selbst bei. Es folgt ein Aufenthalt in Paris, wo er sich als Student an der Kunstakademie (Ecole supérieure nationale des Beaux-Arts) einschreibt. Anschliessend hält er sich einige Zeit in London auf, wo er die Villa eines jüdischen Millionärs restauriert. Zurück in der Schweiz, arbeitet er frei als Werbe-Gestalter. Ein Unterrichtspraktikum am Kinderdorf Pestalozzi Trogen zeigt seine Begabung als Lehrer. In der Folge absolviert Walter Grässli die Ausbildung zum Lehrer für Bildnerisches Gestalten an der Zürcher Hochschule der Künste (ZHdK) und schliesst mit dem Diplom für das Höhere Lehramt für Bildnerisches Gestalten ab (Gymnasiallehrer). Intensive Weiterbildung an der Universität Zürich. Grässli unterrichtet 35 Jahre lang als Lehrer an der Kantonsschule Wattwil, parallel dazu auch einige Zeit an der ZHdK (Farbenlehre). In dieser Zeit findet auch einige Jahre lang eine intensive Auseinandersetzung mit Kunstgeschichte (Universität Zürich) und mit der Theorie der Farbe statt. Parallel dazu zahlreiche Ausstellungen im In- und Ausland und die Veröffentlichung mehrerer Publikationen (Quelle: Graesslihomepage). Sprache: Deutsch Gewicht in Gramm: 300.
Seller: Chiron Media, Wallingford, United Kingdom
paperback. Condition: New.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In.
Language: English
Published by Taylor & Francis Ltd, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Paperback / softback. Condition: New. New copy - Usually dispatched within 4 working days.
Condition: New.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition.
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 192 pages. 10.00x7.00x1.18 inches. In Stock.
Condition: New.
Published by Nimbus. Kunst und Bücher, 2014
ISBN 10: 3038500089 ISBN 13: 9783038500087
Seller: Antiquariat UEBUE, Zürich, Switzerland
Softcover. Condition: Sehr gut. Limitierte Ausgabe. Z : 13 x 22 cm, 160 Seiten - Limitierte Ausgabe No 166/200 Ex. und 167/200.
Condition: NEW.
Language: English
Published by Taylor & Francis Ltd, London, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Seller: CitiRetail, Stevenage, United Kingdom
Paperback. Condition: new. Paperback. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD. This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Language: English
Published by TAYLOR & FRANCIS NP EXCLUSIVE(CBS), 2025
ISBN 10: 1032170239 ISBN 13: 9781032170237
Seller: UK BOOKS STORE, London, LONDO, United Kingdom
Condition: New. Brand New ! Fast Delivery "International Edition " and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 4-6 Working days .and we do have flat rate for up to 2LB. Extra shipping charges will be requested This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Condition: New.
Language: English
Published by Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Seller: Rarewaves USA United, OSWEGO, IL, U.S.A.
Paperback. Condition: New. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD.